• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 3. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropylamines

Introduction to 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine and Its Significance in Modern Chemical Research

2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine, with the CAS number 1552103-18-0, represents a compound of considerable interest in the realm of pharmaceutical and chemical research. This molecule, characterized by its unique structural and functional attributes, has garnered attention due to its potential applications in the development of novel therapeutic agents. The presence of both fluoro and methoxy substituents in its aromatic ring system imparts distinct electronic and steric properties, making it a valuable scaffold for medicinal chemists.

The chemical structure of 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine consists of a propylamine moiety attached to a phenyl ring that is substituted at the 3rd and 5th positions with fluoro atoms and at the 2nd position with a methoxy group. This specific arrangement not only influences the compound's solubility and metabolic stability but also plays a crucial role in its interactions with biological targets. The fluoro atoms, known for their ability to modulate pharmacokinetic properties, contribute to the compound's lipophilicity and binding affinity, while the methoxy group enhances its metabolic stability.

In recent years, there has been a growing interest in the development of fluorinated aromatic compounds due to their enhanced bioavailability and improved pharmacological profiles. The incorporation of fluoro atoms into drug molecules has been widely recognized for its ability to improve binding affinity, reduce metabolic degradation, and enhance drug efficacy. Similarly, the presence of methoxy groups is often associated with increased metabolic stability and better pharmacokinetic properties. These attributes make 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine a promising candidate for further investigation in drug discovery.

The synthesis of 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine involves several key steps that highlight the importance of precision and expertise in organic chemistry. The process typically begins with the preparation of the 3,5-difluoro-2-methoxybenzaldehyde, which serves as the core aromatic precursor. This intermediate is then subjected to reductive amination with propylamine to yield the desired amine derivative. The reaction conditions must be carefully controlled to ensure high yield and purity, as impurities can significantly affect the compound's pharmacological properties.

The role of computational chemistry in the study of 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine cannot be overstated. Advanced computational methods, such as molecular dynamics simulations and quantum mechanical calculations, have been instrumental in understanding its structural and electronic properties. These techniques provide insights into how the compound interacts with biological targets at the molecular level, aiding in the design of more effective derivatives. Additionally, computational studies help predict potential side effects and optimize dosing regimens.

In recent research endeavors, 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine has been explored for its potential applications in treating various diseases. For instance, studies have indicated that this compound exhibits inhibitory activity against certain enzymes implicated in inflammatory responses. The unique combination of substituents enhances its binding affinity to these enzymes, potentially leading to more effective therapeutic outcomes. Furthermore, preliminary studies suggest that it may have applications in neurodegenerative diseases due to its ability to cross the blood-brain barrier.

The pharmacokinetic profile of 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine is another area of active investigation. Fluorinated compounds are known for their improved bioavailability and reduced susceptibility to metabolic degradation. Studies have shown that this compound exhibits favorable pharmacokinetic properties when administered orally or intravenously. These findings are crucial for determining optimal dosing regimens and formulating effective drug delivery systems.

The environmental impact of fluorinated compounds is also a subject of increasing interest. While these compounds offer significant therapeutic benefits, their persistence in the environment raises concerns about long-term ecological effects. Researchers are actively exploring strategies to minimize these impacts while maintaining their pharmacological efficacy. One approach involves designing fluorinated compounds that are biodegradable or can be easily metabolized by environmental microorganisms.

The future prospects for 2-(3,5-difluoro-2-methoxyphenyl)propan-1-amine are promising given its unique structural features and potential therapeutic applications. Ongoing research aims to further optimize its pharmacological properties through structural modifications and derivatization strategies. Additionally, exploring new synthetic routes could enhance production efficiency and reduce costs associated with its development.

In conclusion, 2-(3,5-difluoro-2-methoxyphenyl)propan-1-am ine (CAS no: 1552103–18–0) represents a significant advancement in pharmaceutical chemistry due to its innovative structure and promising therapeutic applications. Its unique combination of substituents enhances its bioactivity and pharmacokinetic profile while presenting opportunities for further research and development. As scientific understanding continues to evolve，this compound is poised to play an increasingly important role in modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)